Related Experiment Video
Updated: Feb 15, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
The utilization of nonprescription medications in Saudi patients with cardiovascular diseases
Eman M Shorog1,2, Khalid A Alburikan1
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Insights
Many cardiovascular disease patients in Saudi Arabia use nonprescription medications, including herbal products and over-the-counter drugs. This common practice necessitates healthcare provider discussions to prevent adverse drug events and manage cardiovascular conditions effectively.
Area of Science:
- Pharmacology
- Public Health
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death in Saudi Arabia, with increasing incidence.
- Nonprescription medication use in CVD patients poses risks of adverse drug events and interactions with prescribed therapies.
- Understanding nonprescription medication patterns is crucial for managing CVD patient safety.
Purpose of the Study:
- To investigate the patterns of nonprescription medication utilization among patients with cardiovascular diseases.
- To identify factors associated with the use of nonprescription medications in this patient population.
Main Methods:
- A cross-sectional study was conducted at a tertiary health care center's Cardiology Clinics.
- Data collected included sociodemographics, medical history, nonprescription medication use (OTC, supplements, herbal), and information sources.
- Multivariate logistic regression analyzed predictors of nonprescription medication use.
Main Results:
- 116 out of 209 (55%) CVD patients reported routine nonprescription medication use.
- Commonly used nonprescription products included black seeds, garlic, acetaminophen, cold/cough remedies, and ibuprofen.
- Diabetes mellitus was associated with higher nonprescription medication use.
Conclusions:
- Routine nonprescription medication use is prevalent among cardiovascular disease patients for various reasons.
- Healthcare providers must proactively address nonprescription medication use with CVD patients.
- Early intervention can mitigate potential harmful outcomes associated with nonprescription drug use in CVD management.
Background:
Cardiovascular diseases (CVDs) are the most common cause of disease-related death in Saudi Arabia. The incidence of CVDs continues to increase, presenting a major health care problem. Nonprescription medications are widely used by patients with CVD and may cause adverse drug events, either by worsening the disease or by harmfully interacting with prescribed medications. We investigated the patterns of nonprescription medication utilization and the factors associated with their use in patients with CVD.
Methods:
This was a cross-sectional study conducted at the Cardiology Clinics of an academic tertiary health care center. Participants were asked about their sociodemographic characteristics, medical history and frequency of using nonprescription medications including over-the-counter (OTC) products, dietary supplements, and herbal products. Moreover, we investigated the participants' sources of information about nonprescription medications. Multivariate logistic regression analysis was conducted to examine the predictors of nonprescription medication use.
Results:
A total of 209 participants were interviewed. The mean age of the participants was 56 ± 15 years, and 110 (52.6%) were female. Of the 209 participants, 116 (55%) reported routine use of nonprescription medications. Black seeds and garlic were the most frequently used herbal products. Acetaminophen, cold/cough remedies, and ibuprofen were the most commonly reported OTC drugs. Of the surveyed patients, 54 (46.5%) used nonprescription medications to manage cardiovascular conditions specifically. Compared with other comorbidities, diabetes mellitus was associated with a higher use of nonprescription medications.
Conclusion:
In patients with CVD, the routine use of nonprescription medications was common for a number of reasons. Health care providers should proactively discuss nonprescription use with their CVD patients to avoid potential harmful outcomes.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease III: Medical Management
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Inhaled Medications
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...